ATE263560T1 - Neue verwendung von citreamicinen - Google Patents

Neue verwendung von citreamicinen

Info

Publication number
ATE263560T1
ATE263560T1 AT01929832T AT01929832T ATE263560T1 AT E263560 T1 ATE263560 T1 AT E263560T1 AT 01929832 T AT01929832 T AT 01929832T AT 01929832 T AT01929832 T AT 01929832T AT E263560 T1 ATE263560 T1 AT E263560T1
Authority
AT
Austria
Prior art keywords
citreamicins
new use
coch2ch
coch3
typically
Prior art date
Application number
AT01929832T
Other languages
English (en)
Inventor
Puentes Jose Luis Fernandez
Fernandez Librada M Canedo
Gravalos Dolores Garcia
Julia Perez-Baz
Francisco Romero-Millan
Fernando Espliego-Vazquez
Original Assignee
Inst Biomar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biomar Sa filed Critical Inst Biomar Sa
Application granted granted Critical
Publication of ATE263560T1 publication Critical patent/ATE263560T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01929832T 2000-05-17 2001-05-17 Neue verwendung von citreamicinen ATE263560T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0011927.1A GB0011927D0 (en) 2000-05-17 2000-05-17 New use of citreamicins
PCT/GB2001/002148 WO2001087283A2 (en) 2000-05-17 2001-05-17 New use of citreamicins

Publications (1)

Publication Number Publication Date
ATE263560T1 true ATE263560T1 (de) 2004-04-15

Family

ID=9891785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01929832T ATE263560T1 (de) 2000-05-17 2001-05-17 Neue verwendung von citreamicinen

Country Status (9)

Country Link
US (1) US20030236291A1 (de)
EP (1) EP1292299B1 (de)
JP (1) JP2003533474A (de)
AT (1) ATE263560T1 (de)
AU (1) AU2001256512A1 (de)
CA (1) CA2408837A1 (de)
DE (1) DE60102695D1 (de)
GB (1) GB0011927D0 (de)
WO (1) WO2001087283A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016020D0 (en) 2000-06-29 2000-08-23 Inst Biomar Sa New polyciclic xanthones and their use
WO2009085360A2 (en) * 2007-10-04 2009-07-09 Novobiotic Pharmaceuticals Llc Citreamicin antibiotic with a sugar residue
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599650B2 (en) * 1986-05-16 1990-07-26 Taiho Pharmaceutical Co., Ltd. Substance 4181-2 and its derivatives
EP0353381A3 (de) * 1988-08-04 1991-01-02 American Cyanamid Company Antibiotika LL-E 19085 Alpha
EP0405151A1 (de) * 1989-06-29 1991-01-02 American Cyanamid Company Antibiotikum LL-E19085
EP0442003A1 (de) * 1990-02-13 1991-08-21 American Cyanamid Company Antibiotikum LL-E 19085 alpha
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents

Also Published As

Publication number Publication date
US20030236291A1 (en) 2003-12-25
WO2001087283A2 (en) 2001-11-22
AU2001256512A1 (en) 2001-11-26
GB0011927D0 (en) 2000-07-05
WO2001087283A3 (en) 2002-04-25
CA2408837A1 (en) 2001-11-22
JP2003533474A (ja) 2003-11-11
EP1292299B1 (de) 2004-04-07
DE60102695D1 (de) 2004-05-13
EP1292299A2 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
NL350077I2 (nl) Cyprosulfamide
DE69910831D1 (de) Epothilonderivate und ihre verwendung als antitumormittel
MY120511A (en) New pesticides
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
BG103590A (en) Pesticide 1-arylpyrazols
ATE342927T1 (de) Nicht-elastomere polyurethanzusammensetzungen
TR199901282T2 (xx) Heterosiklik olarak ikame edilmi� yeni benzamitler.
TR200002921T2 (tr) Yarı-Sentetik ekteinasidinler
SE0004245D0 (sv) Novel compounds and their use
DK1042319T3 (da) Dihydrobenzofuraner
MXPA02006217A (es) 2-(ih-indol-3-il)-2-oxo-acetamidas con actividad antitumoral.
ATE297903T1 (de) Substituierte phenyluracile
SE9903290D0 (sv) Novel compounds
DK1204659T3 (da) Serotonerge benzofuraner
ATE280169T1 (de) Serotonerge benzothiophene
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
DE69102762D1 (de) Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
ATE263560T1 (de) Neue verwendung von citreamicinen
ATE232732T1 (de) 2',5'-phosphorthioat/phosphodiester- oligoadenylate und ihre antiviralen verwendungen
ATE370156T1 (de) Makrolide
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
TR200401422T4 (tr) Yeni trioksepan bileşikleri
PT1140932E (pt) Derivados de 1,8-benzonaftiridina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties